1. Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019, Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw, 17(8), 896-909. Retrieved Jul 16, 2020, https://jnccn.org/view/journals/jnccn/17/8/article-p896.xml
2. Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81(1):17-38. doi:10.1007/s00280-017-3501-8
3. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Études des Cancers de l'Ovaire (GINECO). Cancer. 2009;115(6):1234-1244. doi:10.1002/cncr.24149
4. Rinaldy D, Andrijono, Sutrisna B. The Outcomes of Primary Debulking Surgery and Neoadjuvant Chemotherapy in Advanced Ovarian Cancer. Indones J Obstet Gynecol Vol 4, no2. April 2016
5. Kehoe S, Hook J, Nankivell M, et all. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 2015;386:249.
6. Spriggs DR, Zivanovic O. Ovarian Cancer Treatment- Are We Getting Warmer? N Engl J Med 2018; 378:293.
7. Van Meurs HS, Tajik P, Hof MH, et al. Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial. Eur J Cancer 2013; 49:3191.
8. Coleridge SL, Bryant A, Lyons TJ, Goodall RJ, Kehoe S, Morrison J. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD005343. DOI: 10.1002/14651858.CD005343.pub4.
9. Thrall MM, Gray HJ, Symons RG, et al. Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer. Gynecol Oncol, 2011; 123:461.
10. Vergote I, Trope CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010; 363:943.
11. Vergote I, Denys H, De Greve J, Gennigens C, Van De Vijver K, Kerger J, Vuylsteke P, Baurain JF. Treatment algorithm in patients with ovarian cancer. Facts Views Vis Obgyn. 2020 Oct 8;12(3):227-239. PMID: 33123697; PMCID: PMC7580261.
12. Kurnit KC, Fleming GF, Lengyel E. Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment. Obstet Gynecol. 2021 Jan 1;137(1):108-121. doi: 10.1097/AOG.0000000000004173. PMID: 33278287; PMCID: PMC7737875.
13. Coleridge, Sarah L, et al. “Chemotherapy versus Surgery for Initial Treatment in Advanced Ovarian Epithelial Cancer.” Cochrane Database of Systematic Reviews, 2021, doi:10.1002/14651858.cd005343.pub5.